Given that MCF‐7 is a type of breast cancer cells expressing ERα but without expression of HER2 41, the cross‐talk mediating the acquired endocrine resistance was contributed to IGF‐1‐induced mTOR pathway. Here, ERBB2 is linked to breast cancer.